Rana Hassan, PA
Medical · Ashburn, VANPI 1508993833
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Galderma Laboratories, L.p. at 56.7% of the total. Reporting peaked in 2023 at $24,839 and has fallen 70.7% since, to $7,276 in 2025. Among medical clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,042 payments — averaging $52.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$31K
- Pfizer$5K
- AbbVie$2K
- Incyte Corporation$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
- Sun Pharmaceutical Industries Inc.$1K
- plus $12K from 27 others
What the payments were for
- Consulting fees$7501%
- Speaking & faculty fees$28,42052%
- Travel & lodging$3,3766%
- Food & beverage$21,61940%
- Education$3151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 92 | $30,917 |
| Pfizer | 71 | $4,700 |
| AbbVie | 102 | $2,192 |
| Incyte Corporation | 96 | $1,821 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 89 | $1,473 |
| Sun Pharmaceutical Industries Inc. | 76 | $1,398 |
| Regeneron Healthcare Solutions, Inc. | 45 | $1,273 |
| Lilly USA, LLC | 65 | $1,200 |
| E.r. Squibb & Sons, L.L.C. | 49 | $1,175 |
| Sanofi | 35 | $1,165 |
| Arcutis Biotherapeutics, Inc. | 79 | $1,160 |
| Journey Medical Corporation | 7 | $1,025 |
| Johnson & Johnson | 39 | $919 |
| Novartis | 44 | $838 |
| UCB, Inc. | 40 | $790 |
| Dermavant Sciences, Inc. | 22 | $364 |
| LEO Pharma Inc. | 19 | $358 |
| Boston Scientific | 12 | $284 |
| Medimetriks Pharmaceuticals, Inc. | 10 | $202 |
| VYNE Pharmaceuticals Inc. | 6 | $197 |
| Almirall LLC | 5 | $185 |
| Amgen | 7 | $141 |
| Organon | 6 | $140 |
| EPI Health, LLC | 5 | $96 |
| Verrica Pharmaceuticals Inc. | 5 | $90 |
| Mayne Pharma Commercial LLC | 4 | $90 |
| Janssen Scientific Affairs, LLC | 1 | $76 |
| Boehringer Ingelheim | 2 | $50 |
| Smith+Nephew | 3 | $43 |
| Biofrontera Inc. | 2 | $41 |
| Kyowa Kirin, Inc. | 2 | $35 |
| Botanix SB Inc | 1 | $24 |
| Organogenesis Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,480 in reported general payments places this provider in the 95th percentile of 632 medical providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $115,691 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 12 | $4,769 |
| Clobetasol Propionate | 45 | $3,148 |
| Pimecrolimus | 11 | $3,060 |
| Metronidazole | 19 | $1,423 |
| Clindamycin Phosphate | 24 | $1,261 |
| Fluocinonide | 16 | $1,042 |
| Ciclopirox | 24 | $911 |
| Triamcinolone Acetonide | 73 | $695 |
| Desonide | 12 | $687 |
| Ketoconazole | 43 | $605 |
| Mometasone Furoate | 20 | $404 |
| Econazole Nitrate | 11 | $328 |
| ValacyclovirValacyclovir Hcl | 12 | $282 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $267 |
Paid to pharmacies, not to this prescriber.
Other medical in Ashburn
- Bryan UrquhartFredericksburg$264K
- Sara VillalonaRichmond$240K
- Sarah SafaLansdowne$171K
- Waseem GarbiaFairfax$114K
- Brian LamFalls Church$42K
- Christine KesslerKing George$20K
- Janlyn AnthonyRichmond$18K
- Cara DepanfilisNorfolk$17K
- Nicholas DeptulaRichmond$17K
- Caitlin FortuneReston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.